Actively Recruiting
Green LEP vs ThuLEP in Management of Marked Enlarged Prostate
Led by Mansoura University · Updated on 2024-10-30
110
Participants Needed
1
Research Sites
395 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study the investigators aim to test TGreenlight (532-nm) laser Photoselective Enucleation of the Prostate (Green LEP) using (XPS) 180W system ) vs Thulium Laser 200 W Enucleation of the Prostate (ThuLEP) in reduction of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) in a randomized controlled trial. Furthermore, all peri-operative parameters, urinary flow parameters, prostate size changes and complications associated with the procedures will be compared.
CONDITIONS
Official Title
Green LEP vs ThuLEP in Management of Marked Enlarged Prostate
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 40 years or older
- Lower urinary tract symptoms due to bladder outlet obstruction from benign prostatic hyperplasia that did not improve with medical treatment
- International prostate symptom scores (IPSS) greater than 15 and quality of life bother score of 3 or more
- Peak urinary flow rate less than 15 ml/sec with at least 125 ml voided volume, or acute urine retention secondary to BPH that failed medical treatment
- American Society of Anesthesiologists (ASA) score of 3 or less
- Prostate size 80 ml or larger as measured by transrectal ultrasound (TRUS)
You will not qualify if you...
- Neurological disorders affecting bladder function, such as stroke or Parkinson's disease
- Active urinary tract infection
- Active bladder cancer within the last 2 years
- Known prostate cancer based on examination, PSA levels, imaging, or biopsy
- Blood clotting disorders or platelet function disorders that increase bleeding risk
- Unable to stop anticoagulant or antiplatelet therapy before surgery (except low-dose aspirin)
- Recent acute myocardial infarction or open-heart surgery within 180 days prior to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Urology and Nephrology Center
Al Mansurah, Dakahlia Governorate, Egypt
Actively Recruiting
Research Team
M
Mahmoud Nabil Laymon, MD
CONTACT
A
Adel M Nabeeh, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here